Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medibank Private ( (AU:MPL) ) has issued an update.
Medibank Private has notified the market of the issue of 22,184 unquoted performance rights under its employee incentive scheme, with an effective issue date of 30 March 2026. The additional performance rights, which are not intended to be quoted on the ASX, reflect the ongoing use of equity-based remuneration to align staff incentives with shareholder interests and may lead to a modest increase in potential share-based compensation over time.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$4.85 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is an Australian private health insurance provider listed on the ASX under the code MPL. The company offers health insurance products and related services to individuals and groups, operating in the broader healthcare and insurance industry across Australia.
YTD Price Performance: -5.53%
Average Trading Volume: 7,531,517
Technical Sentiment Signal: Buy
Current Market Cap: A$12.23B
Learn more about MPL stock on TipRanks’ Stock Analysis page.